KPTI
Karyopharm Therapeutics Inc. · Healthcare
EVP and Chief Medical Officer Reshma Rangwala sold $25K of Karyopharm Therapeutics Inc.
Sold$25,493
$1.18Price
21,636Shares
−6%Stake
What KPTI did after the filing
- The stock from Mon, Mar 4 close, $19.65
- −16.0%
- S&P 500, same days
- −1.4%
Measured over 30 trading days, to the Apr 16 close.
Traded Thu, Feb 29. Filed Mon, Mar 4, 2:41 PM ET, during the session. Returns use the Mar 4 close and the Apr 16 close. Not investment advice.